News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
At 18's now, the HOD, way undervalued and market seems to be sleeping on it, word is slowly spreading though
IDK, but the chart was telling me a breakout over 8's was imminent, see my post a couple weeks ago, chart said to me something was stirring and now today the breakout on the news, charts forcast news events, proven here.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174546410
Yeah, the chart saw it coming, that's why I bought, from the chart, not the news
Here's the breakout I called for! Another chart win!!!
massive
CBIH Achieves $2 Billion Valuation Following StoneBridge Advisory Assessment
Newsfile Corp.
Newsfile Corp
Houston, Texas--(Newsfile Corp. - June 17, 2024) - Cannabis Bioscience International Holdings (OTC PINK: CBIH) has been valued at $2 Billion following a rigorous evaluation by StoneBridge Advisory, a leading financial advisory firm based in Los Angeles, California.
StoneBridge's assessment highlights CBIH's formidable market presence, cutting-edge product offerings, and solid business framework. Moreover, this valuation serves as a testament to investor and analyst optimism regarding CBIH's capacity for sustained growth and expansion.
The valuation was reached through a comprehensive review of CBIH's financial metrics, market penetration, industry competition, and strategic planning. Additionally, it took into account the exceptional skill sets within the company. Including securities attorney; corporate attorney, patent attorney, in-house counsel, comptroller with a Magister Scientiarum in Administration, CPA, PCAOB, graphic designer, Master's Degree in Audiovisual Communication and Advertising Content, Ph.D.-level scientists with emphasis on microbiology, medical professionals certified in cancer biology, peritoneal dialysis, pregnancy-related emergency care, as well as board-certified in General medicine and internal medicine, Anti-aging medicine Specialist, Master of Health Care Administration, and Doctorate in Dental Surgery. These experts have contributed to the development of a diversified portfolio of innovative therapies and medical solutions over the past 15 years. Their work addresses gaps in conventional treatments, and provides natural alternatives for widespread health issues globally.
StoneBridge Advisory employed meticulous due diligence and sophisticated financial modeling during the valuation process to guarantee precision and accurately represent the value of CBIH.
John Jones, Treasurer and Director of CBIH, commented on the significance of this valuation, stating: "We have been meticulously reconstructing our company and reinforcing its foundations. Given the promising opportunities we've identified, obtaining a valuation became the next logical step to gauge our progress and plan for future growth." He further noted, "Being positioned in rapidly evolving sectors like medical cannabis, clinical research, and biotechnology, coupled with our unparalleled expertise, positions us uniquely to seize advantageous opportunities that will benefit both our company and shareholders."
This landmark $2 Billion valuation positions CBIH among an elite group of startups and fresher/emerging companies that have achieved such a notable feat. This milestone paves the way for CBIH to pursue strategic alliances, investment opportunities, and ambitious expansion strategies, further cementing its status as a leader in the cannabis bioscience sector.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. The words "believe," "expect," "should," "intend," "estimate," "projects," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company's current expectations and are subject to a number of risks, uncertainties, and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company's filings, which are on file at www.OTCmarkets.com.
For more information contact us at:
(214) 733-0868
ir@cbih.net
Dante Picazo
CEO - CBIH
Website: www.cbih.net
X: www.twitter.com/cbihstock
Instagram: www.instagram.com/CBIHSTOCK
Investor Relations:
East Coast
Peter Nicosia
Bull in Advantage, LLC
Phone: 585-703-6565
Email: Info@BlueHorseshoeStocks.com
West Coast
Zach Logan
Pacific Capital Markets LLC
Phone: 858.864.0011
Email: pacificcapitalmarketsllc@gmail.com
https://images.newsfilecorp.com/files/10188/213088_b92b11ca44633888_logo.jpg
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/213088
SOURCE Cannabis Bioscience International Holdings
https://api.newsfilecorp.com/newsinfo/213088/130
https://www.otcmarkets.com/stock/CBIH/news/story?e&id=2892259
Hey scammer, haven't heard here from you much lately, wonder why 
Not to mention the ENDV & MIKP boards..yo where you hiding at? Come face the music 
Oh, and I'm not a disgruntled "investor" so you can stop floating that narrative. I wouldn't dump a cent into your POS stocks. Just well aware of you & what you & that sh_t-bag Leupold do..
$CBIH Check it out! https://www.vitabiotech.in/
Vita Biotech Retains CBIH Services for Clinical Studies
"Vita Biotech will act as a financial subsidiary and catalyst for CBIH's data collection trials"
Breakout over 8's appears imminent!
Vita Biotech Retains CBIH Services for Clinical Studies
Newsfile Corp.
Newsfile Corp
Houston, Texas--(Newsfile Corp. - June 5, 2024) - Vita Biotech Research has entered into a significant partnership with Cannabis Bioscience International Holdings (OTC Pink: CBIH), to fund the clinical data collection efforts of CBIH's rigorous data clinical studies, underscoring Vita Biotech's commitment to supporting cutting-edge research and ensuring the highest standards of clinical data integrity.
Through this strategic alliance, Vita Biotech will act as a financial subsidiary and catalyst for CBIH's data collection trials, a vital phase in evaluating the efficacy and safety of its formulations before they reach the market. This accelerated funding is expected to speed up CBIH's progress toward its scientific and commercial goals.
Furthermore, this collaboration allows CBIH to chart a course of its reconstruction process as it facilitates to isolate each medical formulation into a unique legal entity. This risk management strategy aligns with industry practices aimed at simplifying financing and partnerships, streamlining intellectual property and licensing processes.
The choice of Texas as the jurisdiction for patent housing is driven by its business-friendly environment, including favorable judicial precedents, cost-effective litigation, and access to federal courts adept in handling complex cases. Therefore, this calculated maneuver would place CBIH in a strong defensive posture in the event of legal challenges, and it is foreseen to lessen potential legal liabilities of the parent corporation.
The decision to proceed with this collaboration followed medical legal standards to mitigate any potential medical conflicts arising from the studies, upholding ethical standards to maintain credibility and executing CBIH's protocols effectively, which could lead to improved statistical significance.
"The nature of clinical trials and data collection necessitates a cooperative endeavor between different entities, each bringing unique advantages to the table, without compromising the integrity and safety of data management during the trials. This way we take a significant leap forward in both organizations' missions and the enhancement of patient care," says Dr. Jennifer Salguero, PhD in Science specialized in Microbiology from São Paulo Brazil University, and VITA's Director of Clinical Trial Operations.
Overall, this partnership offers a platform for funding CBIH's projects, safeguards both parties from risks related to intellectual property and litigation, and ensures the meticulous and ethical collection of data. CBIH and Vita Biotech look forward to potentially bolster the credibility of our research among leading pharmaceutical companies, paving the way as pioneers in medical cannabis clinical research.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. The words "believe," "expect," "should," "intend," "estimate," "projects," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company's current expectations and are subject to a number of risks, uncertainties, and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company's filings, which are on file at www.OTCmarkets.com.
For more information contact us at:(214) 733-0868
ir@cbih.net
Dante Picazo
CEO - CBIH
Website: www.cbih.net
X: www.twitter.com/cbihstockInstagram: www.instagram.com/CBIHSTOCK
Investor Relations:
East Coast
Peter Nicosia
Bull in Advantage, LLC
Phone: 585-703-6565
Email: Info@BlueHorseshoeStocks.com
West Coast
Zach Logan
Pacific Capital Markets LLC
Phone: 858.864.0011
Email: pacificcapitalmarketsllc@gmail.com
https://images.newsfilecorp.com/files/10188/211751_687e9dd4b440484c_logo.jpg
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/211751
SOURCE Cannabis Bioscience International Holdings
https://api.newsfilecorp.com/newsinfo/211751/130
https://www.otcmarkets.com/stock/CBIH/news/story?e&id=2882133
$CBIH Price is cheap and holding up! Potential Merger was announced earlier, when that happens CBIH will be flying up real high! https://www.cbih.net/
BUSINESS DESCRIPTION
The company is dedicated to providing services in all therapeutic areas of clinical research through one of our products: Alpha Research Institute, LLC. a Houston-based Research Unit that offers phase I to phase IV Clinical Research Studies. The Company also operates an international learning platform that provides knowledge about cannabinoids' medical benefits: Pharmacology University. We have been researching medical cannabis uses for more than 15 years, as a result, we have published ebooks, audiobooks, videos, and magazines. Cannabis Bioscience International Holdings will unite both experiences, clinical studies, and knowledge about cannabinoids.
It's holding up!
CBIH I've seen this climb, when it climbs it'll go high!
Please be patient. The last couple of days we did nothing but to water the plant, we are under a couple of non circumvent / non disclosure agreements, thank you for your interest. pic.twitter.com/I409GJKzTx
— CBIH (@CBIHstock) March 14, 2024
Bought 11's here today!
$CBIH Nice day! Merger and other excellent news are incoming!
$CBIH
Blessed to be part of the greatest medical cannabis company on the OTCMKTS $CBIH - synonym of the future of cannabis medicine https://t.co/Wr3n9RlXD3
— CBIH (@CBIHstock) March 10, 2024
CBIH @CBIHstock
Houston, Texas--(Newsfile Corp. - March 6, 2024) - Cannabis Bioscience International Holdings, Inc. (OTC Pink: $CBIH) announces that Dante Picazo, its chief executive officer, is contributing one billion shares of his common #stock to the Company. These #shares will be retired and have the status of authorized and unissued shares. As a result of this contribution, the number of the Company's outstanding shares has been reduced to approximately 9.4 billion. Since current management assumed control of the Company in 2019, its members have contributed 5.5 billion shares to the Company for no or nominal consideration. The shares have a #market price of approximately $5 million, valued at the closing price of $0.0009 on March 5, 2024. The Company believes that Mr. Picazo's contribution will increase #shareholdervalue
https://ca.finance.yahoo.com/news/cbih-announces-retirement-one-billion-130000159.html
#retirementofshares #stockstowatch #aistocks #MarketNews
5:14 AM · Mar 6, 2024
$CBIH Progress in the making: Possible Merger!
Excellent week! CBIH is talking to a couple of great medical companies about a possible merger.
#CBIH #stock #medicine #medicalcannabis #biotechnology
Brian Cuban Joins Cannabis Bioscience International Holdings as an Advisory Board Member.
https://www.otcmarkets.com/stock/CBIH/news/Brian-Cuban-Joins-Cannabis-Bioscience-International-Holdings-as-an-Advisory-Board-Member?id=431463
@CBIHstock Feb 20
$CBIH Cannabis Bioscience International Holdings, Inc. Announces Engagement of Bull in Advantage as its Investor Relations Firm https://wsj.com/articles/cannabis-bioscience-international-holdings-inc-announces-engagement-of-bull-in-advantage-as-its-investor-relations-firm-57129896 via
@WSJ #Cannabisstocks #Pennystocks #Pharmastocks #Stockfocuslist #Stockstowatch #Pharmaceutical #Biotechnology…
Show more
CBIH Profile. https://www.otcmarkets.com/stock/CBIH/profile
https://www.cbih.net/_files/ugd/172074_675abb627ad4498285cdfa4186ec23e4.pdf
$CBIH https://t.co/Wr3n9RlXD3 pic.twitter.com/L5iF4ngioh
— CBIH (@CBIHstock) March 2, 2024
Yeah, let's do it! CBIH has been a good runner in the past!
$CBIH Brian Cuban Joins Cannabis Bioscience International Holdings as an Advisory Board Member. Newsfile Corp.
Houston, Texas--(Newsfile Corp. - February 26, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is excited to announce that Brian Cuban has been elected by our firm as an Advisory Board Member. Mr. Cuban will bring decades of experience in legal and corporate leadership, and a long track record of coaching diverse professionals around the world.
|
Followers
|
204
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
11787
|
|
Created
|
11/08/09
|
Type
|
Free
|
| Moderators | |||
